Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancers|November 14, 2023
Use of Optical Genome Mapping to Detect Structural Variants in NeuroblastomaRuby G Barford, Emily Whittle, Laura Weir, et al.
Cancers|December 10, 2021
MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast CancerDiana E Baxter, Lisa M Allinson, Waleed S Al Amri, et al.
International Journal of Molecular Sciences|October 16, 2025
Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNAMarina Danilenko, Sharanya Nath, Jack Baines, et al.
Genes, Chromosomes & Cancer|August 27, 2022
Loss of ALK hotspot mutations in relapsed neuroblastomaLisa M Allinson, Aaron Potts, Angharad Goodman, et al.
Molecular Cancer Therapeutics|December 28, 2019
Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast CancerWaleed S Al Amri, Lisa M Allinson, Diana E Baxter, et al.
Oncotarget|November 6, 2015
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemiaAshleigh Herriott, Susan J Tudhope, Gesa Junge, et al.
JCO Precision Oncology|July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN StudyHannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
Pageof 1